Dec 8, 2025 by David Dierking3 Vanguard ETFs to Buy With $1,000 and Hold ForeverVanguard's lineup of ultra-cheap, broadly diversified ETFs is ideal for long-term wealth creation.
Dec 7, 2025 by David DierkingThis High-Yield ETF Has Increased Payouts 13 Years Straight -- and It's Still UndervaluedThe Schwab U.S. Dividend Equity ETF (SCHD) has built a flawless record of increasing its dividend payments every single year since launch.
Dec 6, 2025 by David DierkingThis AI ETF Could Dominate for Decades to ComeAI is the biggest technological revolution since the internet. This ETF is the purest actively managed way to invest in it.
Dec 5, 2025 by David DierkingHere's How Many Shares of the Vanguard High Dividend Yield ETF (VYM) You'd Need for $500 in Yearly DividendsThe Vanguard High Dividend Yield ETF delivers steady and predictable income for investors seeking above-average yields.
Dec 5, 2025 by David DierkingIs the Vanguard S&P 500 ETF a Buy Now?Solid corporate earnings, Fed rate cuts, and optimism about the AI sector could fuel another leg higher for the S&P 500.
Dec 4, 2025 by David DierkingIs the Schwab U.S. Dividend Equity ETF a Buy Now?The ETF's methodology may be sound, but it has been out of step with the trends driving growth on Wall Street lately.
Dec 4, 2025 by David DierkingThe 1 Vanguard ETF That Warren Buffett's Recent Remarks Suggest He Would Buy Right NowBuffett spent years telling retail investors that their smartest long-term move is owning a low-cost S&P 500 fund. And he likes Vanguard's.
Nov 25, 2025 by David DierkingWhy Now Could Be the Right Time to Buy the Defiance Quantum ETFQuantum computing is advancing fast. This fund gives investors an early, diversified way in.
Nov 23, 2025 by David DierkingWhy the Sprott Uranium Miners ETF Could Be One of the Smartest Energy Plays of the AI EraAI's soaring electricity demand is putting quiet but strong momentum behind nuclear energy and the miners fueling it.
Nov 18, 2025 by David DierkingThings Could Be Changing for Bond Investors. This ETF Is Worth a Look.Falling rates, cracks in the labor market, and recession fears mean long-duration Treasuries might be worth a fresh look.
Nov 17, 2025 by David DierkingBiotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.The SPDR S&P Biotech ETF is a compelling investment option.
Nov 10, 2025 by David DierkingWhy XLU Could Be the Quiet Winner of the AI Power BoomData center electricity demand is creating an unexpected growth story for a sector that rarely sees one, and it's helping drive this ETF higher.
